GB2144630B - Pharmaceutical composition containing chitosan - Google Patents

Pharmaceutical composition containing chitosan

Info

Publication number
GB2144630B
GB2144630B GB08408036A GB8408036A GB2144630B GB 2144630 B GB2144630 B GB 2144630B GB 08408036 A GB08408036 A GB 08408036A GB 8408036 A GB8408036 A GB 8408036A GB 2144630 B GB2144630 B GB 2144630B
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
composition containing
containing chitosan
chitosan
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08408036A
Other languages
English (en)
Other versions
GB8408036D0 (en
GB2144630A (en
Inventor
William G Malette
Herbert J Quigley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of GB8408036D0 publication Critical patent/GB8408036D0/en
Publication of GB2144630A publication Critical patent/GB2144630A/en
Application granted granted Critical
Publication of GB2144630B publication Critical patent/GB2144630B/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/36—Materials or treatment for tissue regeneration for embolization or occlusion, e.g. vaso-occlusive compositions or devices

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
GB08408036A 1983-08-12 1984-03-28 Pharmaceutical composition containing chitosan Expired GB2144630B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/522,492 US4452785A (en) 1982-11-08 1983-08-12 Method for the therapeutic occlusion

Publications (3)

Publication Number Publication Date
GB8408036D0 GB8408036D0 (en) 1984-05-10
GB2144630A GB2144630A (en) 1985-03-13
GB2144630B true GB2144630B (en) 1988-03-30

Family

ID=24081086

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08408036A Expired GB2144630B (en) 1983-08-12 1984-03-28 Pharmaceutical composition containing chitosan

Country Status (4)

Country Link
US (1) US4452785A (enExample)
JP (1) JPS6042326A (enExample)
CA (1) CA1233749A (enExample)
GB (1) GB2144630B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0684309B2 (ja) * 1986-03-24 1994-10-26 ライオン株式会社 人工唾液組成物
ATE201788T1 (de) * 1987-11-12 2001-06-15 Canon Kk Flüssigkristallgerät
US5180426A (en) * 1987-12-28 1993-01-19 Asahi Kogaku Kogyo K.K. Composition for forming calcium phosphate type setting material and process for producing setting material
JP2798287B2 (ja) * 1989-02-08 1998-09-17 ユニチカ株式会社 抗炎症剤
US6150581A (en) * 1995-06-07 2000-11-21 United States Surgical Corporation Chitosan/alginate anti-adhesion barrier
EP0879068A4 (en) 1996-02-02 1999-04-21 Transvascular Inc METHODS AND APPARATUS FOR STOPPING BLOOD FLOW IN VESSELS
US7897832B2 (en) * 2001-06-14 2011-03-01 Hemcon Medical Technologies, Inc. Compositions, assemblies, and methods applied during or after a dental procedure to ameliorate fluid loss and/or promote healing, using a hydrophilic polymer sponge structure such as chitosan
US7371403B2 (en) 2002-06-14 2008-05-13 Providence Health System-Oregon Wound dressing and method for controlling severe, life-threatening bleeding
BR0210406A (pt) * 2001-06-14 2006-04-04 Providence Health Sys Oregon curativo de ferimento, e, métodos de controle de sangramento severo, e de produção de um curativo de ferimento capaz de controlar o sangramento severo
US8741335B2 (en) 2002-06-14 2014-06-03 Hemcon Medical Technologies, Inc. Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as Chitosan
US20060004314A1 (en) * 2001-06-14 2006-01-05 Hemcon, Inc. Antimicrobial barriers, systems, and methods formed from hydrophilic polymer structures such as chistosan
US20050147656A1 (en) * 2001-06-14 2005-07-07 Hemcon, Inc. Tissue dressing assemblies, systems, and methods formed from hydrophilic polymer sponge structures such as chitosan
US8269058B2 (en) * 2002-06-14 2012-09-18 Hemcon Medical Technologies, Inc. Absorbable tissue dressing assemblies, systems, and methods formed from hydrophilic polymer sponge structures such as chitosan
US20050137512A1 (en) * 2003-12-23 2005-06-23 Campbell Todd D. Wound dressing and method for controlling severe, life-threatening bleeding
WO2005081866A2 (en) 2004-02-23 2005-09-09 Loma Linda University Medical Center Hemostatic agent for topical and internal use
WO2006089167A1 (en) * 2005-02-18 2006-08-24 Cartilix, Inc. Glucosamine materials
US9204957B2 (en) * 2005-03-17 2015-12-08 Hemcon Medical Technologies, Inc. Systems and methods for hemorrhage control and or tissue repair
EP2026850B1 (en) * 2006-05-23 2014-07-09 Providence Health System-Oregon d/b/a Providence St. Vincent Medical Center Systems and methods for introducing and applying a bandage structure within a body lumen or hollow body organ
CA2723172A1 (en) * 2008-05-02 2009-11-05 Providence Health System-Oregon D/B/A Providence St. Vincent Medical Cen Ter Wound dressing devices and methods
EP2340002B1 (en) 2008-10-06 2015-03-25 Providence Health System - Oregon Foam medical devices and methods
EP2504039A4 (en) 2009-11-25 2014-07-02 Univ Loma Linda Med HEMOSTATIC TEXTILE BASED ON CHITOSAN
CA2838793C (en) * 2011-07-19 2019-08-06 Baxter International Inc. Resorption enhancers as additives to improve the oral formulation of non-anticoagulant sulfated polysaccharides
US9192574B2 (en) 2013-10-24 2015-11-24 Medtronic Xomed, Inc. Chitosan paste wound dressing
US9192692B2 (en) 2013-10-24 2015-11-24 Medtronic Xomed, Inc. Chitosan stenting paste
US9259357B2 (en) 2014-04-16 2016-02-16 Loma Linda University Composition, preparation, and use of chitosan shards for biomedical applications

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3911116A (en) * 1970-04-13 1975-10-07 Leslie L Balassa Process for promoting wound healing with chitin derivatives
US3989535A (en) * 1974-02-11 1976-11-02 American Cyanamid Company Solution of poly(N-acetyl-D-glucosamine)
JPS5626049A (en) * 1979-08-06 1981-03-13 Mitsubishi Rayon Co Chitine or chitine derivative nonwoven fabric and method
JPS56106901A (en) * 1980-01-30 1981-08-25 Mitsubishi Rayon Co Ltd Production of formed product of chitosan
US4394373A (en) * 1981-04-06 1983-07-19 Malette William Graham Method of achieving hemostasis
US4532134A (en) * 1981-04-06 1985-07-30 Malette William Graham Method of achieving hemostasis, inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound

Also Published As

Publication number Publication date
GB8408036D0 (en) 1984-05-10
CA1233749A (en) 1988-03-08
JPH054370B2 (enExample) 1993-01-19
US4452785A (en) 1984-06-05
GB2144630A (en) 1985-03-13
JPS6042326A (ja) 1985-03-06

Similar Documents

Publication Publication Date Title
GB2136807B (en) Pharmaceutical compositions
DE3466476D1 (en) External pharmaceutical composition
DE3467703D1 (en) Pharmaceutical compositions
GB2144630B (en) Pharmaceutical composition containing chitosan
GB8313217D0 (en) Pharmaceutical compositions
GB8325494D0 (en) Pharmaceutical compositions
GB8415975D0 (en) Pharmaceutical compositions
GB8308126D0 (en) Pharmaceutical compositions
GB8325496D0 (en) Pharmaceutical compositions
GR80293B (en) Pharmaceutical composition
CY1678A (en) Pharmaceutical compositions
GB2136806B (en) Pharmaceutical compositions
GB8317595D0 (en) Pharmaceutical compositions
CY1503A (en) Pharmaceutical compositions
GB8323553D0 (en) Pharmaceutical compositions
GB8417154D0 (en) Pharmaceutical composition
GR80238B (en) Pharmaceutical compositions
GB8407735D0 (en) Pharmaceutical composition
GB8305697D0 (en) Pharmaceutical compositions
GB8300767D0 (en) Pharmaceutical compositions
GB8416358D0 (en) Pharmaceutical compositions
GB8308414D0 (en) Pharmaceutical composition
GB2150435B (en) Pharmaceutical compositions
GB8329216D0 (en) Pharmaceutical composition
GB8327122D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19940328